News Kenvue Inc.

Equities

KVUE

US49177J1025

Personal Products

Market Closed - Nyse Other stock markets 21:00:02 20/04/2026 BST			5-day change	1st Jan Change
17.58 ^USD	-0.17%		+1.33%	+1.91%

04-15	Kimberly-Clark Discloses Organizational Structure After Planned Kenvue Acquisition	MT
04-15	Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal	RE

All News

04-15	Kimberly-Clark Discloses Organizational Structure After Planned Kenvue Acquisition	MT
04-15	Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal	RE
04-15	Kenvue Inc. Appoints Heather Howlett as Interim Chief Financial Officer, Effective May 12, 2026	CI
04-15	Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership	PR
04-15	Citigroup Adjusts Kenvue Price Target to $19 From $20, Maintains Neutral Rating	MT
04-14	Barclays Adjusts Price Target on Kenvue to $18 From $19, Maintains Equalweight Rating	MT
04-14	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
04-13	From Walmart to Nestle, CEO churn sweeps global consumer goods makers	RE
04-07	UBS Adjusts Kenvue Price Target to $18 From $19, Maintains Neutral Rating	MT
03-31	Big-ticket consumer deals over past few decades	RE
03-30	Big-ticket consumer deals over past few decades	RE
03-27	Neutrogena, Aveeno And Rogaine Part of the Kenvue portfolio Debut New Dermatology Research And Clinical Skincare Innovations	CI
03-24	From Walmart to Nestle, CEO churn sweeps global consumer goods makers	RE
03-20	Big-ticket consumer deals over past few decades	RE
03-16	Fortune Brands Innovations Plans to Replace Incoming CEO	MT
03-06	Tylenol use among women dropped after Trump tied it to autism, Lancet analysis shows	RE
03-05	Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating	MT
02-26	Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol safety	RE
02-26	Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge	MT
02-26	Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge	MT
02-26	Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge, Reuters Reports	MT
02-26	Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol safety	RE
02-26	Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol	RE
02-26	Judge rejects Kenvue bid to dismiss Texas Attorney General's lawsuit over marketing of Tylenol, court order shows	RE
02-24	Fortune Brands Faces Pressure From Investor Ed Garden Over CEO Appointment	MT